Table 2. The 10 most significantly cancer associated SELDI peaks in the tissue analysis.
| Peak | P-value (Wilcoxon's test) | Intensity ratio (C/N) |
|---|---|---|
| CM10 mz 2491 | 4.77 × 10−6 | 0.166 |
| IMAC mz 7475 | 6.68 × 10−6 | 0.278 |
| IMAC mz 3375* | 9.54 × 10−6 | 2.164 |
| CM10 mz 4039 | 1.81 × 10−5 | 0.176 |
| IMAC mz 3447* | 2.38 × 10−5 | 1.998 |
| CM10 mz 5836 | 2.38 × 10−5 | 3.006 |
| CM10 mz 3446* | 3.15 × 10−5 | 2.962 |
| CM10 mz 2380 | 3.15 × 10−5 | 0.184 |
| IMAC mz 2515 | 4.10 × 10−5 | 0.254 |
| CM10 mz 6563 | 4.10 × 10−5 | 2.596 |
For each peak, we show the P-value (Wilcoxon's test) and the ratio of the median peak height in cancer patients divided by the median peak height in non-cancer controls. The peaks marked with asterisks are HNP 1 (molecular weight=3448) and HNP 2 (molecular weight=3377).